British Prime Minister Rishi Sunak has been wrapped up in a new conflict of interest row allegations have cropped up against him that his family would financially benefit from a post-brexit trade deal between India and the UK the controversy comes ahead of his visit to India for the G20 Summit next month since this year both India and the UK have been negotiating to implement a free trade deal trade
experts and parliamentarians have raised concerns over potential transparency issues related to sunak's wife akshita murti's shareholdings in Infosys Infosys is a Bengaluru based I.T company founded by her father Ana narayanamurthy in May Infosys was valued at about 63 billion dollars according to Reports most of the enormous wealth accumulated by sunak and his wife comes from this it firm as per reports
Infosys has had contracts with the UK government and companies there reports said that the company is Keen to improve access to the European country for its thousands of contract workers through changes in the UK Visa regime for the proposed trade deep granting visas to workers in sectors such as it and artificial intelligence is a key Indian demand in talks over The Pact the UK on the other hand wants a slash
in high tariffs on Indian Goods exports including cars and Scotch whiskey the opposition labor party demanded that sunak should be more open and transparent in revealing his wife's Financial interests amid concerns that Infosys could benefit from the prospective treat deal one expert said that the British prime minister should recuse himself from the trade talks altogether given the sensitivities over the trade
negotiations the UK foreign office has warned the Committee Against conducting a trip to India this Autumn to examine potential issues related to the agreement the latest controversy came after sunuk was criticized by the UK Parliament standards Watchdog for not properly declaring his wife's separate shareholding in a child care firm that stood to benefit due to the new policy changes of the government Videolytics .
0 Comments